CMS Measure ID: #110 Collection Type: MVP Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Community, Population andContinue reading “2023 # 110 Preventive Care and Screening: Influenza Immunization”
CQM/MVP Archive
2023 # 438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS Measure ID: #438 Collection Type: CQM, eCQM, MVP Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: EffectiveContinue reading “2023 # 438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease”
2023 # 024 Communication with the Physician or Other Clinician Managing On-going Care Post-Fracture for Men and Women Aged 50 Years and Older
CMS Measure ID: #24 Collection Type: CQM Reporting Frequency: Every visit Outcome: No High Priority: Yes NQS Domain: Communication and Care Coordination Measure Age:Continue reading “2023 # 024 Communication with the Physician or Other Clinician Managing On-going Care Post-Fracture for Men and Women Aged 50 Years and Older”
2023 # 493 Adult Immunization Status
CMS Measure ID: #493 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 493 Adult Immunization Status”
2023 # 463 Prevention of Post-Operative Vomiting (POV) – Combination Therapy (Pediatrics)
CMS Measure ID: #463 Collection Type: CQM Reporting Frequency: Every visit Outcome: No High Priority: Yes NQS Domain: Patient Safety Measure Age: > 2Continue reading “2023 # 463 Prevention of Post-Operative Vomiting (POV) – Combination Therapy (Pediatrics)”
2023 # 450 Appropriate Treatment for Patients with Stage I (T1c) – III HER2 Positive Breast Cancer
CMS Measure ID: #450 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Effective Clinical CareContinue reading “2023 # 450 Appropriate Treatment for Patients with Stage I (T1c) – III HER2 Positive Breast Cancer”
2023 # 451 RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy
CMS Measure ID: #451 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 451 RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy”
2023 # 452 Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies
CMS Measure ID: #452 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Patient Safety MeasureContinue reading “2023 # 452 Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies”
2023 # 453 Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better)
CMS Measure ID: #453 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Effective Clinical CareContinue reading “2023 # 453 Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better)”
2023 # 457 Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score – better)
CMS Measure ID: #457 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: Yes High Priority: Yes NQS Domain: Effective Clinical CareContinue reading “2023 # 457 Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score – better)”